{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T22:50:43Z","timestamp":1770418243301,"version":"3.49.0"},"reference-count":23,"publisher":"Informa UK Limited","issue":"1-2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia & Lymphoma"],"published-print":{"date-parts":[[1998,1]]},"DOI":"10.3109\/10428199809058394","type":"journal-article","created":{"date-parts":[[2008,1,29]],"date-time":"2008-01-29T15:50:09Z","timestamp":1201621809000},"page":"187-192","source":"Crossref","is-referenced-by-count":6,"title":["All Trans Retinoic Acid with Low Dose Cytosine Arabinoside in the Treatment of Myelodysplastic Syndrome"],"prefix":"10.1080","volume":"29","author":[{"given":"Reena","family":"Nair","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, Tata Memorial Hospital, Parel, Mumbai, 400 012, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chandrika N.","family":"Nair","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Tata Memorial Hospital, Parel, Mumbai, 400 012, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suresh H.","family":"Advani","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Tata Memorial Hospital, Parel, Mumbai, 400 012, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2009,7]]},"reference":[{"key":"e_1_2_1_2_1","first-page":"284","article-title":"Myelodysplastic syndromes (Preleukemia)","volume":"23","author":"Koeffler H. P","year":"1986","unstructured":"Koeffler H. P. Myelodysplastic syndromes (Preleukemia). Sem Hamatol 1986; 23: 284\u2013299","journal-title":"Sem Hamatol"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-112-12-932"},{"key":"e_1_2_1_4_1","first-page":"85","article-title":"Myelodysplastic syndromes","volume":"19","author":"Cheson B. D","year":"1992","unstructured":"Cheson B. D. Myelodysplastic syndromes. Sem Oncol 1992; 19: 85\u201394","journal-title":"Sem Oncol"},{"key":"e_1_2_1_5_1","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1182\/blood.V82.10.2967.2967","article-title":"All trans retinoic acid in the management of patients with mylodysplastic syndrome. Results of a pilot study","volume":"82","author":"Aul C.","year":"1993","unstructured":"Aul C., Runde V., Gattermann N. All trans retinoic acid in the management of patients with mylodysplastic syndrome. Results of a pilot study. Blood 1993; 82: 2967\u20132974","journal-title":"Blood"},{"key":"e_1_2_1_6_1","first-page":"774","article-title":"Induction of differentiation of human myeloid leukemia cells by inhibitors of DNA synthesis","volume":"10","author":"Griffin J.","year":"1982","unstructured":"Griffin J., Munroe D., Mayor P., et al. Induction of differentiation of human myeloid leukemia cells by inhibitors of DNA synthesis. Exp Hematol 1982; 10: 774\u2013781","journal-title":"Exp Hematol"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/0145-2126(85)90136-5"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1987.tb06893.x"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/0753-3322(92)90084-K"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1982.tb08475.x"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.1986.tb01345.x"},{"key":"e_1_2_1_12_1","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1182\/blood.V67.4.1154.1154","article-title":"Response of hematopoietic precursors to 13\u2010cisretinoic acid and 1,25 dihydroxy vitamin D3 in the Myelodysplastic syndromes","volume":"67","author":"Swanson G.","year":"1986","unstructured":"Swanson G., Picozzi V., Morgan R., Hecht F., Greenberg P. Response of hematopoietic precursors to 13\u2010cisretinoic acid and 1,25 dihydroxy vitamin D3 in the Myelodysplastic syndromes. Blood 1986; 67: 1154","journal-title":"Blood"},{"key":"e_1_2_1_13_1","first-page":"181","article-title":"Low dose cytosine arabinoside in patients with myelodysplastic syndrome","volume":"44","author":"Nair R.","year":"1996","unstructured":"Nair R., Saikia T. K., Gopal R., et al. Low dose cytosine arabinoside in patients with myelodysplastic syndrome. J Assoc Phys Ind 1996; 44: 181\u2013183","journal-title":"J Assoc Phys Ind"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/84.17.1332"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V79.2.299.299"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1128\/mcb.10.5.2154-2163.1990"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1139\/o87-021"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.112.5.965"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428199409049696"},{"issue":"3","key":"e_1_2_1_20_1","first-page":"369","article-title":"Effects of combination therapy with all trans retinoic acid and recombinant human granulocyte colony stimulating factor in patients with myelodysplastic syndrome","volume":"8","author":"Ganser A.","year":"1994","unstructured":"Ganser A., Seipelt G., Verbeck W., et al. Effects of combination therapy with all trans retinoic acid and recombinant human granulocyte colony stimulating factor in patients with myelodysplastic syndrome. Leuk 1994; 8(3)369\u2013375","journal-title":"Leuk"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1159\/000218467"},{"key":"e_1_2_1_22_1","first-page":"249","article-title":"Fourth International Workshop on chromosomes in leukemia 1982: A prospective study of acute non lymphocytic leukemia","volume":"11","year":"1984","unstructured":"Fourth International Workshop on chromosomes in leukemia 1982: A prospective study of acute non lymphocytic leukemia. Cancer Genet Cytogenet 1984; 11: 249","journal-title":"Cancer Genet Cytogenet"},{"key":"e_1_2_1_23_1","first-page":"215a","article-title":"Evaluation of low dose Ara\u2010C versus supportive care in the treatment of myelodysplastic syndrome: An intergroup study by the Eastern Co\u2010operative Oncology Group and South West Oncology Group","volume":"72","author":"Miller K. M.","year":"1988","unstructured":"Miller K. M., Kim K., Morrison F. S., et al. Evaluation of low dose Ara\u2010C versus supportive care in the treatment of myelodysplastic syndrome: An intergroup study by the Eastern Co\u2010operative Oncology Group and South West Oncology Group. Blood 1988; 72: 215a, (abstr 771)","journal-title":"Blood"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-117-4-292"}],"container-title":["Leukemia & Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.3109\/10428199809058394","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T11:32:34Z","timestamp":1770377554000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.3109\/10428199809058394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,1]]},"references-count":23,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[1998,1]]}},"alternative-id":["10.3109\/10428199809058394"],"URL":"https:\/\/doi.org\/10.3109\/10428199809058394","relation":{},"ISSN":["1042-8194","1029-2403"],"issn-type":[{"value":"1042-8194","type":"print"},{"value":"1029-2403","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,1]]}}}